Bangkok Dusit Medical Services Public Company Limited (BDUUF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 20.94 means the share price is 20.94 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $10.2B is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBangkok Dusit Medical Services Public Company Limited (BDUUF) trades at $0.64. Bangkok Dusit Medical Services (BDUUF) is a leading healthcare provider in Thailand and Cambodia, operating 47 hospitals. Market cap: $10.2B, Sector: Healthcare.
Price as of Sep 10, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for BDUUF: BDUUF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BDUUF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
BDUUF: 2/2 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Bangkok Dusit Medical Services Public Company Limited (BDUUF) Healthcare & Pipeline Overview
Bangkok Dusit Medical Services (BDUUF) is a prominent healthcare provider in Thailand and Cambodia, managing 47 hospitals under six established groups. The company distinguishes itself through integrated services, including wellness programs, hotels, and e-commerce, alongside core medical offerings, capitalizing on medical tourism and regional healthcare demand.
What Is the Investment Thesis for BDUUF?
The company's network of 47 hospitals and diverse revenue streams provide a stable foundation. With a P/E ratio of 20.94 and a profit margin of 14.2%, BDUUF demonstrates financial health. A dividend yield of 5.29% offers an attractive return for investors. Growth catalysts include expansion of medical tourism, increasing demand for healthcare services in Thailand and Cambodia, and strategic investments in specialized medical fields. Potential risks include regulatory changes, economic fluctuations, and competition from other healthcare providers.
Based on FMP financials and quantitative analysis
BDUUF Key Highlights
Market Cap of $10.2B reflects BDUUF's significant presence in the healthcare sector.
- P/E Ratio of 20.94 indicates a reasonable valuation compared to earnings.
- Profit Margin of 14.2% demonstrates efficient operations and profitability.
- Gross Margin of 36.1% highlights the company's ability to manage costs effectively.
- Dividend Yield of 5.29% provides an attractive income stream for investors.
Who Are BDUUF's Competitors?
BDUUF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| GIFLF Grifols, S.A. | $11.33 | +2.26% | $7.71B | 529-signal |
| MTHRF M3, Inc. | $10.36 | 0.00% | $6.92B | 489-signal |
| RCDTF Recordati Industria Chimica e Farmaceutica S.p.A. | $58.00 | 0.00% | $11.9B | — |
| ENSG The Ensign Group, Inc. | $172.79 | +0.60% | $10.1B | 745-pillar |
| UHS Universal Health Services, Inc. | $172.72 | -1.74% | $10.5B | 935-pillar |
| DVA DaVita Inc. | $181.33 | -0.92% | $11.6B | 745-pillar |
| FMS Fresenius Medical Care AG & Co. KGaA | $22.23 | -0.45% | $11.9B | 825-pillar |
| EHC Encompass Health Corporation | $121.04 | -0.40% | $12.0B | 895-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are BDUUF's Key Strengths?
Strong brand reputation in Thailand and Cambodia.
- Extensive network of hospitals and clinics.
- Integrated service offerings, including hospitals, hotels, and related businesses.
- Experienced management team.
What Are BDUUF's Weaknesses?
Dependence on the Thai and Cambodian markets.
- Exposure to regulatory changes and economic fluctuations.
- Competition from other healthcare providers.
- Potential for medical malpractice claims.
What Could Drive BDUUF Stock Higher?
Expansion of medical tourism initiatives to attract more international patients.
- Investments in specialized medical services, such as cardiology and oncology.
- Potential strategic partnerships and acquisitions to expand the hospital network.
- Implementation of digital health technologies to improve patient care and access.
- Focus on wellness and preventative care services to cater to the growing demand.
What Are the Key Risks for BDUUF?
Economic downturns in Thailand and Cambodia could reduce demand for healthcare services.
- Changes in government regulations could impact the company's operations and profitability.
- Increased competition from other healthcare providers could erode market share.
- Outbreaks of infectious diseases could disrupt operations and reduce patient volumes.
- Medical malpractice claims could result in significant financial liabilities.
What Are the Growth Opportunities for BDUUF?
- Expansion of Medical Tourism: BDUUF can leverage Thailand's popularity as a medical tourism destination to attract more international patients. The global medical tourism market is projected to reach $272.7 billion by 2027. By offering specialized medical packages and catering to the specific needs of international patients, BDUUF can increase its revenue from this segment. Timeline: Ongoing.
- Increasing Demand for Specialized Medical Services: As the population ages and healthcare awareness increases, there is growing demand for specialized medical services such as cardiology, oncology, and orthopedics. BDUUF can invest in expanding its capabilities in these areas to attract more patients and increase revenue. The market for specialized medical services is expected to grow at a rate of 8-10% annually. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: BDUUF can pursue strategic partnerships and acquisitions to expand its network of hospitals and broaden its service offerings. This can help the company to enter new markets and gain access to new technologies and expertise. The company could look to acquire smaller hospitals or clinics in underserved areas. Timeline: Ongoing.
- Digital Health Initiatives: Investing in telemedicine, remote monitoring, and other digital health technologies can improve access to care, enhance patient engagement, and reduce costs. The digital health market is expected to grow rapidly in the coming years, driven by increasing adoption of smartphones and internet access. BDUUF can develop its own digital health platform or partner with existing providers. Timeline: Upcoming.
- Expansion into Wellness and Preventative Care: BDUUF can expand its focus on wellness and preventative care services to cater to the growing demand for these services. This can include offering health check-ups, wellness programs, and nutritional counseling. The market for wellness and preventative care services is expected to grow at a rate of 6-8% annually. Timeline: Ongoing.
What Are BDUUF's Competitive Advantages?
- Established Brand Reputation: BDUUF has a strong brand reputation in Thailand and Cambodia, built over decades of providing quality healthcare services.
- Extensive Network of Hospitals: The company's large network of hospitals provides a competitive advantage in terms of geographic reach and patient access.
- Integrated Service Offerings: BDUUF's diverse service offerings, including hospitals, hotels, and related businesses, create synergies and enhance customer loyalty.
- Medical Tourism Expertise: The company has developed expertise in attracting and serving international patients, giving it an edge in the medical tourism market.
What Does BDUUF Do?
Bangkok Dusit Medical Services Public Company Limited (BDUUF), established in 1969 and headquartered in Bangkok, Thailand, is a major player in the Southeast Asian healthcare industry. The company operates and manages an extensive network of 47 hospitals across Thailand and Cambodia. These hospitals are organized under six primary groups: Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. BDUUF provides a comprehensive range of medical services, including general and specialized medical care, holistic clinical wellness programs, and diagnostic services. Beyond its core hospital operations, BDUUF has diversified into related businesses, including hotels and restaurants catering to medical tourists and patients' families. The company also sells health and cosmetic products, and provides accounting, health insurance, laboratory, investment, IT, training, telemedicine, genome sequencing, insurance brokerage, air medical transportation, facility management, property management, and asset management services. Further, BDUUF is involved in e-commerce and real estate. This integrated approach allows BDUUF to capture a larger share of the healthcare value chain and enhance patient experience.
What Products and Services Does BDUUF Offer?
- Operates and manages a network of 47 hospitals in Thailand and Cambodia.
- Provides general and specialized medical care services.
- Offers holistic clinical wellness programs.
- Sells health and cosmetic products.
- Provides accounting, health insurance, and laboratory services.
- Offers telemedicine and genome sequencing services.
- Provides air medical transportation and facility management services.
- Engages in e-commerce and real estate activities.
How Does BDUUF Make Money?
- Generates revenue from hospital operations, including medical services, room charges, and pharmacy sales.
- Earns income from related businesses such as hotels, restaurants, and health product sales.
- Provides various support services, including accounting, IT, and training, to its hospitals and other healthcare providers.
- Derives revenue from medical tourism by attracting international patients.
What Industry Does BDUUF Operate In?
Bangkok Dusit Medical Services operates within the growing healthcare industry of Southeast Asia. The region is experiencing increasing demand for quality healthcare services, driven by factors such as aging populations, rising incomes, and growing medical tourism. The competitive landscape includes both local and international hospital groups. BDUUF differentiates itself through its large network of hospitals, diverse service offerings, and established reputation. The company is well-positioned to capitalize on the increasing demand for healthcare services in Thailand and Cambodia.
Who Are BDUUF's Key Customers?
- Local patients seeking general and specialized medical care.
- International patients seeking medical treatment in Thailand and Cambodia.
- Corporations and organizations seeking healthcare services for their employees.
- Individuals seeking wellness and preventative care services.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 52 |
| 2026-08-26 | 52 |
| 2026-08-29 | 52 |
| 2026-09-01 | 52 |
| 2026-09-04 | 52 |
| 2026-09-07 | 52 |
| 2026-09-10 | 52 |
What changed?
The score has stayed at 52.
Over the same 18 days the stock moved +0.0%.
Company Profile
Bangkok Dusit Medical Services Public Company Limited operates in the Medical Care Facilities industry within the Healthcare sector. It is headquartered in Bangkok, Thailand.
Financial Health
Bangkok Dusit Medical Services Public Company Limited's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.53 places it in the safe zone, indicating low near-term bankruptcy risk.
Key Financial Metrics
Return on equity for Bangkok Dusit Medical Services Public Company Limited stands at 14.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.7%, showing how much profit it generates from its asset base. BDUUF trades at a trailing price-to-earnings ratio of 20.94, roughly in line with the Healthcare sector average of ~21.50x. Its free cash flow yield is 4.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.16 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.4%, the inverse of the P/E and a quick read on earnings relative to price.
BDUUF Valuation & Market Position
With a $10.2B market cap, Bangkok Dusit Medical Services Public Company Limited sits in the large-cap segment of the market.
Forward Outlook
Wall Street analysts project Bangkok Dusit Medical Services Public Company Limited revenue of about $114.77B for fiscal 2026, with EPS near $0.00. The estimate reflects 12 contributing analysts.
BDUUF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Strong brand reputation in Thailand and Cambodia.
- Extensive network of hospitals and clinics.
- Integrated service offerings, including hospitals, hotels, and related businesses.
- Experienced management team.
Bear Case
- Dependence on the Thai and Cambodian markets.
- Exposure to regulatory changes and economic fluctuations.
- Competition from other healthcare providers.
- Potential for medical malpractice claims.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
BDUUF Latest News
-
Stocks That Hit 52-Week Highs On Wednesday
· Jan 29, 2020
-
Stocks That Hit 52-Week Highs On Friday
· Oct 4, 2019
BDUUF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BDUUF.
Price Targets
Wall Street price target analysis for BDUUF.
BDUUF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BDUUF; grades run from A+ (80-100) to F (below 30).
Leadership: Poramaporn Prasarttong-Osoth
CEO
Poramaporn Prasarttong-Osoth serves as the Chief Executive Officer of Bangkok Dusit Medical Services Public Company Limited. Her extensive background in the healthcare industry and business management has been instrumental in guiding the company's strategic direction. She has held various leadership positions within the BDMS network, contributing to the growth and expansion of the organization. Her expertise spans across hospital operations, financial management, and corporate strategy.
Track Record: Under Poramaporn Prasarttong-Osoth's leadership, Bangkok Dusit Medical Services has continued to strengthen its position as a leading healthcare provider in the region. She has overseen the expansion of the hospital network, the introduction of new medical technologies, and the implementation of various initiatives to improve patient care and operational efficiency. Her strategic decisions have contributed to the company's financial performance and market capitalization.
BDUUF OTC Market Information
The OTC Other tier represents the lowest tier of over-the-counter (OTC) markets, indicating that Bangkok Dusit Medical Services (BDUUF) may have limited regulatory oversight and reporting requirements compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies on this tier may not meet the minimum financial standards or disclosure requirements necessary for listing on higher-tier exchanges. This tier is also sometimes referred to as the 'Pink Sheets'.
- OTC Tier: OTC Other
- Limited Disclosure: Lack of comprehensive financial reporting and regulatory oversight increases information asymmetry and the risk of fraud.
- Low Liquidity: Low trading volumes can make it difficult to buy or sell shares quickly or at desired prices.
- Price Volatility: The potential for significant price swings due to limited trading activity and market manipulation.
- Operational Risks: Companies on the OTC Other tier may be subject to greater operational risks due to limited resources and oversight.
- Going Concern Risk: There is an elevated risk that the company may not be a viable going concern.
- Verify the company's registration and legal standing.
- Review available financial statements and assess their accuracy and completeness.
- Research the company's management team and their track record.
- Understand the company's business model and competitive landscape.
- Assess the liquidity of the stock and the potential for price volatility.
- Consult with a qualified financial advisor.
- Be aware of the risks associated with investing in OTC stocks.
- Established Operations: The company has been in operation since 1969.
- Extensive Hospital Network: BDUUF operates a large network of hospitals in Thailand and Cambodia.
- Publicly Traded: Although on the OTC market, the company is publicly traded, suggesting some level of scrutiny.
- CEO Profile: Poramaporn Prasarttong-Osoth is listed as the CEO.
BDUUF Healthcare Stock FAQ
Is BDUUF a good stock?
Stock Expert AI does not rate BDUUF buy, sell or hold. Bangkok Dusit Medical Services Public Company Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for BDUUF?
The main risks for Bangkok Dusit Medical Services include economic downturns in Thailand and Cambodia, which could reduce demand for healthcare services.
What are the key factors to evaluate for BDUUF?
Evaluate BDUUF on fundamentals, analyst consensus, and risk factors. P/E: 20.94x vs the S&P 500's ~20-25x. The company's network of 47 hospitals and diverse revenue streams provide a stable foundation. Not financial advice.
How frequently does BDUUF data refresh on this page?
BDUUF's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BDUUF's recent stock price performance?
Bangkok Dusit Medical Services Public Company Limited (BDUUF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation in Thailand and Cambodia. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BDUUF overvalued or undervalued right now?
Bangkok Dusit Medical Services Public Company Limited (BDUUF) trades at 20.94x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of BDUUF?
Yes, most major brokerages offer fractional shares of Bangkok Dusit Medical Services Public Company Limited (BDUUF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track BDUUF's earnings and financial reports?
Bangkok Dusit Medical Services Public Company Limited (BDUUF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for BDUUF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC status requires additional due diligence.